May 2016 FDA Recall Drug by Attix Pharmaceuticals Inc
D-1047-2016 - cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration

This Class III drug recall was voluntarily initiated by Attix Pharmaceuticals Inc on May 18, 2016 for the product Drug. The FDA reported the reason for recall as cgmp deviation; manufacturer is not registered with the food and drug administration. The product was distributed in CO and the recall is currently terminated.

Recall Number: D-1047-2016

Reason for Recall
cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration
Initiated
05-18-2016
Reported
06-29-2016
Quantity
N/A

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Attix Pharmaceuticals Inc
Mycophenolate Mofetil, Bulk Powder, Quantity 1000 g, For prescription compounding use and medical manufacturing or processing only, Attix Pharmaceuticals, Toronto, Canada

Batch or Lot Expiration Information

Lot# Lot Number: A3160A, Manufacturer batch number: 151201, Expiry November 2017